Related Experiment Videos

Aetiology and prognosis of de novo graft membranous nephropathy

Y Pirson, J Ghysen, J P Cosyns

    Proceedings of the European Dialysis and Transplant Association - European Renal Association. European Dialysis and Transplant Association - European Renal Association. Congress
    |January 1, 1985
    PubMed

    Insights

    De novo graft membranous nephropathy (DNGMN) is linked to chronic rejection and occurs more often in well-matched kidney transplants. This condition significantly reduces long-term graft survival, indicating a poor prognosis.

    Area of Science:

    • Nephrology
    • Transplantation immunology
    • Pathology

    Background:

    • De novo graft membranous nephropathy (DNGMN) is a serious complication following kidney transplantation.
    • Understanding its causes and outcomes is crucial for improving patient prognosis.

    Purpose of the Study:

    • To investigate the aetiology and prognosis of de novo graft membranous nephropathy (DNGMN).

    Main Methods:

    • Retrospective review of 25 cases of DNGMN among 1258 kidney transplants.
    • Analysis of graft survival and association with chronic rejection and HLA matching.

    Main Results:

    • DNGMN was observed in 12% of HLA-identical living donor recipients versus 2% in haplo-identical and cadaver donor recipients.
    • A strong association was found between DNGMN and chronic rejection lesions.
    • Graft survival after DNGMN diagnosis was 49% at five years.

    Conclusions:

    • DNGMN is associated with chronic rejection and tends to occur in well-matched kidney grafts.
    • The condition carries a poor prognosis, with significantly reduced graft survival.

    Related Concept Videos